India's Shilpa Medicare can make 100-200 million doses of COVID-19 shot, says executive

The company's shares jumped as much as 9.2% on India's National Stock Exchange following the news.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cUH56h
via IFTTT